For the quarter ending 2025-11-30, SLP had -$664K decrease in cash & cash equivalents over the period. $4,234K in free cash flow.
| Cash Flow | 2025-11-30 | 2025-08-31 | 2025-05-31 |
|---|---|---|---|
| Net income | 676 | -681 | -64,037 |
| Depreciation and amortization | 1,346 | 1,354 | 6,857 |
| Change in fair value of contingent consideration | - | 0 | -640 |
| Impairments | - | 0 | 77,221 |
| Discharge of holdback obligation related to immunetrics acquisition | - | 0 | 224 |
| Amortization of investment discounts | 0 | 0 | -64 |
| Stock-based compensation | 1,615 | 1,524 | 4,830 |
| Deferred income taxes | 168 | 2,655 | -8,081 |
| Loss from disposal of assets | -75 | 0 | -23 |
| Unrealized gains (losses) on available-for-sale securities | 0 | - | - |
| Currency translation adjustments | 6 | -3 | 28 |
| Accounts receivable | 2,437 | -5,063 | 5,644 |
| Prepaid income taxes | -32 | 823 | -1,243 |
| Prepaid expenses and other assets | 835 | 80 | -274 |
| Accounts payable | 393 | -1,193 | 1,061 |
| Other liabilities | 184 | -587 | -2,600 |
| Accrued income taxes | - | 0 | - |
| Deferred revenue | 3,023 | -1,648 | 2,348 |
| Net cash provided by (used in) operating activities | 4,234 | 5,587 | 12,539 |
| Purchases of property and equipment | 0 | 264 | 449 |
| Proceeds from sales of investments | - | 0 | 995 |
| Purchase of short-term investments | 5,500 | 0 | 6,500 |
| Purchase of long-term investments | - | - | 0 |
| Issuance of promissory note | - | 1,000 | - |
| Proceeds from maturities of short-term investments | 1,500 | 0 | 14,017 |
| Purchased intangibles | 11 | 11 | 368 |
| Business acquisition, net of cash acquired | - | 0 | - |
| Net working capital & excess cash settlement - pro-ficiency acquisition | -227 | 227 | 227 |
| Capitalized computer software development costs | 889 | 516 | 2,115 |
| Net cash used in investing activities | -4,900 | -1,791 | 5,353 |
| Payment of dividends | - | 0 | 0 |
| Payments on contracts payable | - | 0 | 1,576 |
| Proceeds from the exercise of stock options | 2 | 107 | 323 |
| Repurchase and retirement of common shares | - | 0 | - |
| Net cash provided by financing activities | 2 | 107 | -1,253 |
| Net decrease in cash and cash equivalents | -664 | 3,903 | 16,639 |
| Cash and cash equivalents at beginning of period | 30,853 | 10,311 | - |
| Cash and cash equivalents at end of period | 30,189 | 30,853 | - |
Simulations Plus, Inc. (SLP)
Simulations Plus, Inc. (SLP)